Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart in Patients with Type 2 Diabetes from a Danish Health-Care Perspective

Overview of attention for article published in Diabetes Therapy, August 2016

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 27 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 1,219 followers.

Cost-Effectiveness of IDegAsp vs BIAsp 30 in Patients with #T2DM from a #Danish Perspective https://t.co/yXi0ix9LeU https://t.co/MT3lr9bhyR

Reply Repost Favourite

Cost-Effectiveness of IDegAsp vs BIAsp 30 in Patients with #Type2Diabetes from a Danish Perspective https://t.co/yXi0ix9LeU #insulin

Reply Repost Favourite